Risk of Uterine Perforation with Levonorgestrel-Releasing and Copper Intrauterine Devices

Risk of uterine perforation with levonorgestrel-releasing and copper intrauterine devices in the European Active Surveillance Study on Intrauterine Devices.

Heinemann K, Reed S, Moehner S, Minh TD. Contraception. 2015 Apr;91(4):274-9.

Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices.

Heinemann K, Reed S, Moehner S, Minh TD. Contraception. 2015 Apr;91(4):280-3.

Knowledge and attitudes of Latin American obstetricians and gynecologists regarding intrauterine contraceptives. Bahamondes L, Makuch MY, Monteiro I, Marin V, Lynen R. Int J Womens Health. 2015 Jul 16;7:717-22.

Non-contraceptive benefits of hormonal and intrauterine reversible contraceptive methods. Bahamondes L, Bahamondes MV, Shulman LP.

Hum Reprod Update. 2015 Sep;21(5):640-51.

Therapy of heavy menstrual bleeding in Korea: Subanalysis and results from a multinational clinical trial in the Asian region investigating the levonorgestrel-releasing intrauterine system versus conventional therapy. Lee BS, Ling X, Asif S, Kraemer P, Hanisch JU, Inki P, Lee JE. Obstet Gynecol Sci. 2015 Mar;58(2):162-70.

Medical management of heavy menstrual bleeding: a comprehensive review of the literature. Bitzer J, Heikinheimo O, Nelson AL, Calaf-Alsina J, Fraser IS.

Obstet Gynecol Surv. 2015 Feb;70(2):115-30.

Cost-effectiveness analysis in the treatment of heavy menstrual bleeding in Spain.

Calaf J, Lete I, Canals I, Crespo C, Espinós B, Cristóbal I. Eur J Obstet Gynecol Reprod Biol. 2015 Jan;184:24-31.

Experience and levels of satisfaction with the levonorgestrel-releasing intrauterine system in China: a prospective multicenter survey. Zhao S, Deng J, Wang Y, Bi S, Wang X, Qin W, Huang Z, Li L, Mi X, Han L, Chang Q, Li J.

Patient Prefer Adherence. 2014 Oct 23;8:1449-55.

Weight variation in users of depot-medroxyprogesterone acetate, the levonorgestrel-releasing intrauterine system and a copper intrauterine device for up to ten years of use. Modesto W, de Nazaré Silva dos Santos P, Correia VM, Borges L, Bahamondes L. Eur J Contracept Reprod Health Care. 2015 Feb;20(1):57-63.

Cancer risk in women using the levonorgestrel-releasing intrauterine system in Finland. Soini T, Hurskainen R, Grénman S, Mäenpää J, Paavonen J, Pukkala E. Obstet Gynecol. 2014 Aug;124(2 Pt 1):292-9.

Provision of no-cost, long-acting contraception and teenage pregnancy.

Secura GM, Madden T, McNicholas C, Mullersman J, Buckel CM, Zhao Q, Peipert JF.

N Engl J Med. 2014 Oct 2;371(14):1316-23.

Satisfaction and health-related quality of life in women with heavy menstrual bleeding; results from a non-interventional trial of the levonorgestrel-releasing intrauterine system or conventional medical therapy. Xu L, Lee BS, Asif S, Kraemer P, Inki P. Int J Womens Health. 2014 May 27;6:547-54.

Bleeding pattern and user satisfaction in second consecutive levonorgestrel-releasing intrauterine system users: results of a prospective 5-year study. Heikinheimo O, Inki P, Schmelter T, Gemzell-Danielsson K. Hum Reprod. 2014 Jun;29(6):1182-8.

Levonorgestrel-releasing intrauterine system vs. usual medical treatment for menorrhagia: an economic evaluation alongside a randomised controlled trial.

Sanghera S, Roberts TE, Barton P, Frew E, Daniels J, Middleton L, Gennard L, Kai J, Gupta JK. PLoS One. 2014 Mar 17;9(3):e91891.

.

Quality of life and costs of levonorgestrel-releasing intrauterine system or hysterectomy in the treatment of menorrhagia: a 10-year randomized controlled trial.

Heliövaara-Peippo S, Hurskainen R, Teperi J, Aalto AM, Grénman S, Halmesmäki K, Jokela M, Kivelä A, Tomás E, Tuppurainen M, Paavonen J. Am J Obstet Gynecol. 2013 Dec;209(6):535.e1-535.e14.

Complications and continuation of intrauterine device use among commercially insured teenagers. Berenson AB, Tan A, Hirth JM, Wilkinson GS.

Obstet Gynecol. 2013 May;121(5):951-8.

Management of initial bleeding or spotting after levonorgestrel-releasing intrauterine system placement: a randomized controlled trial. Sørdal T, Inki P, Draeby J, O'Flynn M, Schmelter T. Obstet Gynecol. 2013 May;121(5):934-41.

Effect of hormonal contraceptives during breastfeeding on infant's milk ingestion and growth. Bahamondes L, Bahamondes MV, Modesto W, Tilley IB, Magalhães A, Pinto e Silva JL, Amaral E, Mishell DR Jr. Fertil Steril. 2013 Aug;100(2):445-50.

The cost-effectiveness of the levonorgestrel-releasing intrauterine system for the treatment of idiopathic heavy menstrual bleeding in the United States. Ganz ML, Shah D, Gidwani R, Filonenko A, Su W, Pocoski J, Law A. Value Health. 2013 Mar-Apr;16(2):325-33.

Levonorgestrel-releasing intrauterine system versus conventional medical therapy for heavy menstrual bleeding in the Asia-Pacific region. Lee BS, Ling X, Asif S, Kraemer P, Hanisch JU, Inki P. Int J Gynaecol Obstet. 2013 Apr;121(1):24-30.

Levonorgestrel intrauterine system versus medical therapy for menorrhagia.

Gupta J, Kai J, Middleton L, Pattison H, Gray R, Daniels J; ECLIPSE Trial Collaborative Group. N Engl J Med. 2013 Jan 10;368(2):128-37.

Five-year follow-up of levonorgestrel-releasing intrauterine system versus thermal balloon ablation for the treatment of heavy menstrual bleeding: a randomized controlled trial.Silva-Filho AL, Pereira Fde A, de Souza SS, Loures LF, Rocha AP, Valadares CN, Carneiro MM, Tavares RL, Camargos AF. Contraception. 2013 Apr;87(4):409-15.

Temporal changes in cervical mucus after insertion of the levonorgestrel-releasing intrauterine system. Natavio MF, Taylor D, Lewis RA, Blumenthal P, Felix JC, Melamed A, Gentzschein E, Stanczyk FZ, Mishell DR Jr. Contraception. 2013 Apr;87(4):426-31.

Bleeding patterns with the levonorgestrel-releasing intrauterine system when used for heavy menstrual bleeding in women without structural pelvic pathology: a pooled analysis of randomized controlled studies. Jensen J, Mansour D, Lukkari-Lax E, Inki P, Burock K, Fraser IS. Contraception. 2013 Jan;87(1):107-12.

Added health benefits of the levonorgestrel contraceptive intrauterine system and other hormonal contraceptive delivery systems.Fraser IS. Contraception. 2013 Mar;87(3):273-9.

Levonorgestrel-releasing intrauterine system for heavy menstrual bleeding improves hemoglobin and ferritin levels. Kaunitz AM, Bissonnette F, Monteiro I, Lukkari-Lax E, DeSanctis Y, Jensen J. Contraception. 2012 Nov;86(5):452-7.

Effectiveness of long-acting reversible contraception. Winner B, Peipert JF, Zhao Q, Buckel C, Madden T, Allsworth JE, Secura GM. N Engl J Med. 2012 May 24;366(21):1998-2007.